Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review

Stereotactic Body Radiation Therapy (SBRT) for Oligorecurrent/Oligoprogressive Mediastinal and Hilar Lymph Node Metastasis: A Systematic Review

Introduction: Mediastinal or hilar lymph node metastases are a challenging condition in patients affected by solid tumors. Stereotactic body radiation therapy (SBRT) could play a crucial role in the therapeutic management and in the so-called “no-fly zone”, delivering high doses of radiation in rela...

Full description

Bibliographic Details
Main Authors:	Salvatore Cozzi, Emanuele Alì, Lilia Bardoscia, Masoumeh Najafi, Andrea Botti, Gladys Blandino, Lucia Giaccherini, Maria Paola Ruggieri, Matteo Augugliaro, Federico Iori, Angela Sardaro, Cinzia Iotti, Patrizia Ciammella
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Cancers
Subjects:	oligorecurrent/oligoprogressive/oligometastatic disease mediastinal and hilar lymph node metastases SBRT salvage treatment stereotactic body radiation therapy ablative radiotherapy
Online Access:	https://www.mdpi.com/2072-6694/14/11/2680

Similar Items

Radiotherapy in Oligometastatic, Oligorecurrent and Oligoprogressive Prostate Cancer: A Mini-Review
by: Alexander Yaney, et al.
Published: (2022-06-01)

Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy
by: Gaëtan Devos, et al.
Published: (2020-08-01)

The Effectiveness and Safety of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Oligoprogressive Breast Cancer: A Systematic Review
by: Bernie Yan, et al.
Published: (2023-07-01)

Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease
by: Jonas Willmann, et al.
Published: (2022-11-01)

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
by: Sabine Gerum, et al.
Published: (2018-05-01)

Long Term Results of Elective Nodal Salvage Radiotherapy in Oligometastatic Prostate Cancer : A Mono-Institutional Series
by: Riccardo Vigna-Taglianti, et al.
Published: (2022-10-01)

Node Oligorecurrence in Prostate Cancer: A Challenge
by: Almudena Zapatero, et al.
Published: (2023-08-01)

Oligometastatic Non-Small Cell Lung Cancer: A Practical Review of Prospective Trials
by: Atallah Baydoun, et al.
Published: (2022-10-01)

Oligoprogression in Non-Small Cell Lung Cancer
by: Daijiro Harada, et al.
Published: (2021-11-01)

Editorial: Novel Applications of Stereotactic Body Radiotherapy (SBRT)
by: Rupesh Kotecha, et al.
Published: (2021-09-01)

Role of Consolidative Stereotactic Body Radiation Therapy in Oligoresistant/Oligoprogressive Pulmonary Parenchymal Metastases
by: Berber T, et al.
Published: (2022-08-01)

Stereotactic Body Radiotherapy for Extracranial Oligometastatic Disease from Head and Neck Primary Cancers: A Systematic Review and Meta-Analysis
by: Adam Mutsaers, et al.
Published: (2024-02-01)

Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature Review
by: Simona Gaito, et al.
Published: (2023-04-01)

Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
by: Chiara Pisano, et al.
Published: (2022-01-01)

Repeated Multimodality Ablative Therapies for Oligorecurrent Pulmonary Metastatic Disease
by: Alban Macagno, et al.
Published: (2022-03-01)

Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases
by: Patrick Berkovic, et al.
Published: (2020-05-01)

Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up
by: Jörg Tamihardja, et al.
Published: (2022-08-01)

Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer
by: Antonin Levy, et al.
Published: (2023-07-01)

Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy
by: Kunal K. Sindhu, et al.
Published: (2022-10-01)

Oligometastatic Disease Detection with <sup>68</sup>Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact
by: Carlos Artigas, et al.
Published: (2021-10-01)

Oligometastatic non-small-cell lung cancer: current treatment strategies
by: Richard PJ, et al.
Published: (2016-11-01)

PEACE V – Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
by: A. De Bruycker, et al.
Published: (2020-05-01)

The Management of Oligoprogression in the Landscape of New Therapies for Metastatic Melanoma
by: Michele Guida, et al.
Published: (2019-10-01)

Pulmonary large cell neuroendocrine carcinoma with adrenal oligorecurrence successfully treated by adrenalectomy
by: Hiroki Sato, et al.
Published: (2020-08-01)

Successful treatment of induced oligometastasis and repeated oligoprogression of advanced lung adenocarcinoma with immunotherapy and radiotherapy
by: Ho Young Lee, et al.
Published: (2022-07-01)

Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity
by: Marcin Miszczyk, et al.
Published: (2023-02-01)

Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations
by: Antonio Rossi, et al.
Published: (2022-02-01)

Durable disease control with local treatment for oligoprogression of metastatic solid tumors treated with immune checkpoint blockade
by: Kunal K. Sindhu, et al.
Published: (2020-01-01)

The Role of Interstitial Brachytherapy for Breast Cancer Treatment: An Overview of Indications, Applications, and Technical Notes
by: Salvatore Cozzi, et al.
Published: (2022-05-01)

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
by: Philipp Hoegen, et al.
Published: (2023-03-01)

Volumetric burden of metastatic lesions drives outcomes in patients with extracranial oligometastatic disease
by: Yilin Cao, et al.
Published: (2021-11-01)

Maximizing Benefits from Maintenance Pemetrexed with Stereotactic Ablative Radiotherapy in Oligoprogressive Non-Squamous Non-Small Cell Lung Cancer
by: Shao-Lun Lu, et al.
Published: (2016-08-01)

Uncovering the armpit of SBRT: An institutional experience with stereotactic radiation of axillary metastases
by: A. Mutsaers, et al.
Published: (2024-03-01)

The Emerging Role of Radiation Therapy in Renal Cell Carcinoma
by: Michael Christensen, et al.
Published: (2022-09-01)

Stereotactic Radiation for Oligometastatic and Oligoprogressive Stage IV Breast Cancer: A Case-Based Review
by: Gary M. Freedman, et al.
Published: (2023-02-01)

Elective nodal radiotherapy with a gapless radiation field junction for oligorecurrent prostate cancer after previous radiotherapy
by: Minglun Li, et al.
Published: (2023-03-01)

Adenoid Cystic Carcinoma/Basal Cell Carcinoma of the Prostate: Overview and Update on Rare Prostate Cancer Subtypes
by: Salvatore Cozzi, et al.
Published: (2022-03-01)

Dose-escalated radiotherapy with simultaneous integrated boost for bone metastases in selected patients with assumed favourable prognosis
by: Potkrajcic Vlatko, et al.
Published: (2022-12-01)

Oligoprogressive Non-Small-Cell Lung Cancer under Treatment with PD-(L)1 Inhibitors
by: Stephan Rheinheimer, et al.
Published: (2020-04-01)

PSMA-PET Guided Treatment in Prostate Cancer Patients with Oligorecurrent Progression after Previous Salvage Treatment
by: Lorenzo Bianchi, et al.
Published: (2023-03-01)